Sönmez, Cüneyt
Wölfer, Johannes
Holling, Markus
Brokinkel, Benjamin
Stummer, Walter
Wiendl, Heinz http://orcid.org/0000-0003-4310-3432
Thomas, Christian
Schulte-Mecklenbeck, Andreas http://orcid.org/0000-0003-3855-4706
Grauer, Oliver M. http://orcid.org/0000-0003-4279-4497
Funding for this research was provided by:
Westfälische Wilhelms-Universität Münster
Article History
Received: 8 February 2022
Accepted: 11 April 2022
First Online: 26 April 2022
Competing interests
: C.S., J.W., M.H, B.B., W.S. and C.T. declare that they have no conflict of interest. A.S.M. received research support and travel expenses from Novartis. H.W. received compensation for serving on scientific advisory boards/steering committees and as a consultant from Bayer Healthcare, Biogen, Sanofi Genzyme, Merck Serono, Roche, and Novartis. He has received speaker honoraria and travel support from Bayer Vital GmbH, Bayer Schering AG, Biogen, CSL Behring, EMD Serono, Fresenius Medical Care, Genzyme, Merck Serono, Omniamed, Novartis, and Sanofi Aventis. H.W. also received research support from Bayer Healthcare, Bayer Vital, Biogen, Merck Serono, Novartis, Sanofi Genzyme, Sanofi US and Teva Pharma, Merck Serono, and Novartis. O.M.G. received speaker honoraria and travel expenses from Roche, Bristol- Myers Squibb and MagForce. He received compensation as a consultant from Gilead Sciences and Bayer AG.